Amir Razaghi
About Amir Razaghi
Amir Razaghi is the Head of Manufacturing Science and Technology at Bristol-Myers Squibb in New Brunswick, NJ, with over 20 years of experience in the pharmaceutical industry.
Title
Amir Razaghi is currently the Head of Manufacturing Science and Technology at Bristol-Myers Squibb, located in New Brunswick, NJ.
Company
Bristol-Myers Squibb is a global biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines that help patients prevail over serious diseases. Amir Razaghi has been with Bristol-Myers Squibb since 2004 and has held multiple leadership roles across various locations, including France, Puerto Rico, and New Jersey.
Education and Expertise
Amir Razaghi has a robust educational background in pharmaceutical sciences. He earned his Bachelor’s degree in Pharmacy from Universidad Complutense de Madrid (1985-1990), a Master’s degree in Pharmaceutical Sciences from Temple University (1991-1993), and a PhD in Pharmaceutics and Drug Design from the University of the Sciences in Philadelphia (1993-1996). This extensive academic journey has established him as an expert in the field of pharmaceutics and drug design.
Background
Amir Razaghi's career in the pharmaceutical industry spans over 20 years. Prior to his current role, he worked as a Senior Research Scientist at Merck in Pennsylvania from 1996 to 2001. He then moved to Schering-Plough Research Institute, where he served as a Manager in Kenilworth, New Jersey from 2001 to 2004. His tenure at Bristol-Myers Squibb began in 2004, and he has served in various capacities, including Associate Director/Director in New Brunswick, Director of Manufacturing Technology in Puerto Rico and France, and finally as the Head of Manufacturing Science and Technology in New Jersey.
Achievements
In his role at Bristol-Myers Squibb, Amir Razaghi holds global responsibility for integrating Global Manufacturing and Supply (GMS) strategic imperatives, including Product Robustness and Global Investigations. He leads the technology transfers of new Active Pharmaceutical Ingredients (API) and Drug Products (DP) and oversees Global Packaging Technology across the Point of Use (POU) and Biologics. His strategic leadership and extensive experience in manufacturing technology have been pivotal in the company's global operations.